148 related articles for article (PubMed ID: 34982978)
1. Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Levy MB; Goldberg MR; Epstein-Rigbi N; Schwartz N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1070-1076.e2. PubMed ID: 34982978
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with home epinephrine-treated reactions during peanut and tree-nut oral immunotherapy.
Nachshon L; Schwartz N; Levy MB; Goldberg MR; Epstein-Rigbi N; Katz Y; Elizur A
Ann Allergy Asthma Immunol; 2023 Mar; 130(3):340-346.e5. PubMed ID: 36509409
[TBL] [Abstract][Full Text] [Related]
3. Severe Anaphylactic Reactions to Home Doses of Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Levy MB; Goldberg M; Epstein-Rigbi N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2524-2533.e3. PubMed ID: 36925102
[TBL] [Abstract][Full Text] [Related]
4. Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Tsviban L; Levy MB; Goldberg MR; Epstein-Rigby N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):185-192.e3. PubMed ID: 32750430
[TBL] [Abstract][Full Text] [Related]
5. Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from the coronavirus disease 2019 lockdown.
Nachshon L; Goldberg MR; Levy MB; Epstein-Rigbi N; Koren Y; Elizur A
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):451-455.e1. PubMed ID: 34010698
[TBL] [Abstract][Full Text] [Related]
6. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of food allergy oral immunotherapy in adults.
Epstein-Rigbi N; Levy MB; Nachshon L; Koren Y; Katz Y; Goldberg MR; Elizur A
Allergy; 2023 Mar; 78(3):803-811. PubMed ID: 36190349
[TBL] [Abstract][Full Text] [Related]
8. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study.
Nachshon L; Goldberg MR; Levy MB; Appel MY; Epstein-Rigbi N; Lidholm J; Holmqvist M; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2019; 7(8):2775-2781.e2. PubMed ID: 31150789
[TBL] [Abstract][Full Text] [Related]
10. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy.
Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; Lidman PG; Yeung J; Vander Leek TK; McHenry M; Wong T; Cook VE; Hildebrand KJ; Gerstner TV; Mak R; Lee NJ; Cameron SB; Chan ES
J Allergy Clin Immunol Pract; 2019; 7(8):2759-2767.e5. PubMed ID: 31002957
[TBL] [Abstract][Full Text] [Related]
11. Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy.
Erdle SC; Cook VE; Cameron SB; Yeung J; Kapur S; McHenry M; Chan ES; Mak R; Rex GA; Wong T; Soller L
J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1177-1183. PubMed ID: 36736958
[TBL] [Abstract][Full Text] [Related]
12. Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
Hofmann AM; Scurlock AM; Jones SM; Palmer KP; Lokhnygina Y; Steele PH; Kamilaris J; Burks AW
J Allergy Clin Immunol; 2009 Aug; 124(2):286-91, 291.e1-6. PubMed ID: 19477496
[TBL] [Abstract][Full Text] [Related]
13. First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy.
Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; McHenry M; Vander Leek TK; Yeung J; Cook VE; Wong T; Hildebrand KJ; Mak R; Gerstner TV; Cameron SB; Chan ES
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1349-1356.e1. PubMed ID: 33221274
[TBL] [Abstract][Full Text] [Related]
14. Peanut allergy and oral immunotherapy.
Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referral.
Koren Y; Nachshon L; Goldberg MR; Levy MB; Epstein-Rigbi N; Elizur A
Pediatr Res; 2023 Feb; 93(3):643-648. PubMed ID: 35641552
[TBL] [Abstract][Full Text] [Related]
16. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.
Virkud YV; Burks AW; Steele PH; Edwards LJ; Berglund JP; Jones SM; Scurlock AM; Perry TT; Pesek RD; Vickery BP
J Allergy Clin Immunol; 2017 Mar; 139(3):882-888.e5. PubMed ID: 27609653
[TBL] [Abstract][Full Text] [Related]
17. Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.
Kim EH; Burks AW
Allergy; 2020 Jun; 75(6):1337-1346. PubMed ID: 32034781
[TBL] [Abstract][Full Text] [Related]
18. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
[TBL] [Abstract][Full Text] [Related]
19. A Web site-based reporting system for monitoring home treatment during oral immunotherapy for food allergy.
Nachshon L; Goldberg MR; Elizur A; Levy MB; Schwartz N; Katz Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):510-5. PubMed ID: 25940735
[TBL] [Abstract][Full Text] [Related]
20. Peanut oral immunotherapy in a pediatric allergy clinic: Patient factors associated with clinical outcomes.
Guarnieri KM; Slack IF; Gadoury-Lévesque V; Eapen AA; Andorf S; Lierl MB
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):214-222.e4. PubMed ID: 33839246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
